Mouse embryonic stem cells express receptors of the insulin family of growth factors

Insulin and insulin‐like growth factors (IGF‐I and ‐II) are members of a family of growth factors which are known to be developmentally regulated during preimplantation mouse embryogenesis. The physiological actions of the insulin family of growth factors are mediated by interactions with specific cell surface receptors that are detectable on the cells of preimplantation mouse embryos. Mouse embryonic stem (ES) cells are totipotent cells derived directly from the inner cell mass of the blastocyst. ES cells have the ability to differentiate into all three germ layers and have unlimited growth potential under certain culture conditions. The great advantage of ES cells is the ability to obtain large amounts of tissue for biochemical studies as compared with preimplantation embryos. To examine in greater detail the biological actions of the insulin family of growth factors, the expression of their cognate receptors on ES cells was examined. ES cells were cultured in DMEM medium supplemented with leukemia inhibitory factor (LIF) to maintain the undifferentiated state. Receptor expression was evaluated at the mRNA level using the reverse transcription polymerase chain reaction (RT‐PCR), and at the protein level by radioactive labeled ligand‐receptor binding assay. Using RT‐PCR, mRNAs of all three growth factor receptors were detected in ES cells. Messenger RNA from ES cells was reverse transcribed into cDNA by AMV reverse transcriptase at 42°C for 1 hr. The reverse transcription reaction was amplified with Taq polymerase and specific primers for insulin, IGF‐I, or IGF‐II receptors by PCR. RT‐PCR and the control plasmid cDNA PCR products were resolved electrophoretically on 3% agarose gels. Each amplified PCR product showed the predicted correct size. The target sequence of RT‐PCR amplified fragments were further verified by restriction enzyme digestion. The expression of receptors at the protein level was confirmed by Scatchard analysis, which showed specific binding of the radiolabeled ligands. This study shows that ES cells may provide a useful model to study the biological actions of the insulin family growth factors. © 1995 wiley‐Liss, Inc.

[1]  H. Collins,et al.  Insulin family growth factors have specific effects on protein synthesis in preimplantation mouse embryos , 1994, Molecular reproduction and development.

[2]  R. Schultz,et al.  Temporal pattern of IGF‐I expression during mouse preimplantation embryogenesis , 1994, Molecular reproduction and development.

[3]  C. Ohlsson,et al.  Embryonic stem cells express growth hormone receptors: regulation by retinoic acid. , 1993, Endocrinology.

[4]  L. Powell-Braxton,et al.  IGF-I is required for normal embryonic growth in mice. , 1993, Genes & development.

[5]  L. Jarett,et al.  Mouse preimplantation embryos exhibit receptor-mediated binding and transcytosis of maternal insulin-like growth factor I. , 1993, Biology of reproduction.

[6]  C. Stewart,et al.  Derivation of embryonic stem cell lines. , 1993, Methods in enzymology.

[7]  D. Rappolee,et al.  Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos. , 1992, Genes & development.

[8]  P. Kaye,et al.  Insulin‐like growth factor‐1 stimulates growth of mouse preimplantation embryos in vitro , 1992, Molecular reproduction and development.

[9]  G. Schultz,et al.  Expression of growth factor ligand and receptor genes in the preimplantation bovine embryo , 1992, Molecular reproduction and development.

[10]  R. Schultz,et al.  Blastocoel expansion in the preimplantation mouse embryo: stimulatory effect of TGF-alpha and EGF. , 1991, Development.

[11]  P. Kaye,et al.  Mouse blastocysts respond metabolically to short‐term stimulation by insulin and IGF‐1 through the insulin receptor , 1991, Molecular reproduction and development.

[12]  A. Efstratiadis,et al.  Parental imprinting of the mouse insulin-like growth factor II gene , 1991, Cell.

[13]  P. Kaye,et al.  Insulin increases cell numbers and morphological development in mouse pre-implantation embryos in vitro. , 1991, Reproduction, fertility, and development.

[14]  C. Mummery,et al.  Expression of growth factors during the differentiation of embryonic stem cells in monolayer. , 1990, Developmental biology.

[15]  G. Schultz,et al.  Expression of genes for insulin and insulin‐like growth factors and receptors in early postimplantation mouse embryos and embryonal carcinoma cells , 1990, Molecular reproduction and development.

[16]  S. Dey,et al.  Preimplantation embryo development in vitro: cooperative interactions among embryos and role of growth factors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Efstratiadis,et al.  A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting , 1990, Nature.

[18]  L. Jarett,et al.  Preimplantation mouse embryos internalize maternal insulin via receptor-mediated endocytosis: pattern of uptake and functional correlations. , 1989, Developmental biology.

[19]  R. Palmiter,et al.  Growth enhancement of transgenic mice expressing human insulin-like growth factor I. , 1988, Endocrinology.

[20]  C Collins,et al.  Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. , 1986, The EMBO journal.

[21]  I. Rosenblum,et al.  Stage-specific insulin binding in mouse preimplantation embryos. , 1986, Developmental biology.

[22]  K. Jarnagin,et al.  The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling , 1985, Cell.

[23]  P. H. Seeburg,et al.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes , 1985, Nature.

[24]  M. Shani,et al.  The nucleotide sequence of the rat cytoplasmic β–actin gene , 1983 .

[25]  J. Hamlin,et al.  Monoiodoinsulin. Preparation, purification, and characterization of a biologically active derivative substituted predominantly on tyrosine A14. , 1974, The Journal of biological chemistry.